Coccidiosis
Reports summarize coccidiosis research from Agricultural Research Service, U.S. Department of Agriculture
Published in Medical Letter on the CDC and FDA, June 27th, 2010
Current study results from the report, 'Eimeria maxima recombinant Gam82 gametocyte antigen vaccine protects against coccidiosis and augments humoral and cell-mediated immunity,' have been published. According to recent research from the United States, "Intestinal infection with Eimeria, the etiologic agent of avian coccidiosis, stimulates protective immunity to subsequent colonization by the homologous parasite, while cross-protection against heterologous species is poor. As a first step toward the development of a broad specificity Eimeria vaccine, this study was designed to assess a purified recombinant protein from Eimeria maxima gametocytes (Gam82) in stimulating immunity against...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- CDC and FDA
New CDC and FDA data have been reported by scientists at Center for Biologics Evaluation and Research - DNA Research
New DNA research reported from Food & Drug Administration - Agrochemicals
New agrochemicals study findings have been reported from Food & Drug Administration - Clinical Hypertension
New clinical hypertension data have been reported by scientists at National Institute for Occupational Safety and Health - U.S. Food and Drug Administration
QPharma, Inc. Announces Engineering Services - U.S. Food and Drug Administration
QuantRx Biomedical Submitted a 510k Application to FDA for Thyroid Point-of-Care Testing System Following Successful Completion of Studies Showing Quantitative Results - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
